Gene Expression in Atherosclerotic Lesion of ApoE Deficient Mice
暂无分享,去创建一个
Per Eriksson | P. Eriksson | S. Stemme | D. Wuttge | A. Sirsjö | Dirk Marcus Wuttge | Allan Sirsjö | Sten Stemme
[1] Gerrity Rg. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981 .
[2] R. Gerrity. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981, The American journal of pathology.
[3] G. Camejo,et al. Effect of arterial proteoglycans on the interaction of LDL with human monocyte-derived macrophages. , 1987, Atherosclerosis.
[4] Kathleen M. Smith,et al. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. , 1988, The Journal of clinical investigation.
[5] G. Hansson,et al. Detection of activated T lymphocytes in the human atherosclerotic plaque. , 1989, The American journal of pathology.
[6] G. Bondjers,et al. Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[7] M. Cybulsky,et al. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.
[8] N. Maeda,et al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[9] P. Libby,et al. Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Ross,et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[11] D. Adams,et al. Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[12] A. Buriani,et al. Mast cells synthesize, store, and release nerve growth factor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[13] S. Skaper,et al. Nerve growth factor and autoimmune diseases. , 1994, Autoimmunity.
[14] K. Pavelić. [What is molecular medicine?]. , 1994, Lijecnicki vjesnik.
[15] J. Witztum,et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[16] M. Aoki,et al. Expression of local hepatocyte growth factor system in vascular tissues. , 1995, Biochemical and biophysical research communications.
[17] P. Bird,et al. A retinoic acid/cAMP-responsive enhancer containing a cAMP responsive element is required for the activation of the mouse thrombomodulin-encoding gene in differentiating F9 cells. , 1996, Gene.
[18] C. Alpers,et al. Platelet-derived growth factor-A mRNA expression in fetal, normal adult, and atherosclerotic human aortas. Analysis by competitive polymerase chain reaction. , 1996, Circulation.
[19] J. Breslow. Mouse Models of Atherosclerosis , 1996, Science.
[20] M. Cybulsky,et al. Immunology of atherosclerosis: the promise of mouse models. , 1996, The American journal of pathology.
[21] B. Johansen,et al. Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[22] S. Bonini,et al. Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. , 1997, The Journal of allergy and clinical immunology.
[23] E. Braunwald. Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.
[24] W. Jiang,et al. Regulation of endothelial CD44 expression and endothelium-tumour cell interactions by hepatocyte growth factor/scatter factor. , 1997, Biochemical and biophysical research communications.
[25] R. Paus,et al. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma , 1998, European journal of immunology.
[26] Y. Nakamura,et al. Gene expression of neurotrophins and their receptors in cultured rat vascular smooth muscle cells. , 1998, Biochemical and biophysical research communications.
[27] R. Ross,et al. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[28] P. Libby,et al. CD40 signaling in vascular cells: a key role in atherosclerosis? , 1998, Atherosclerosis.
[29] R. Hynes,et al. The combined role of P- and E-selectins in atherosclerosis. , 1998, The Journal of clinical investigation.
[30] S. Kunkel. Through the looking glass: the diverse in vivo activities of chemokines. , 1999, The Journal of clinical investigation.
[31] R. Ross. Atherosclerosis is an inflammatory disease , 1999 .
[32] S. Ylä-Herttuala,et al. Functional genomics and DNA array techniques in atherosclerosis research. , 1999, Current Opinion in Lipidology.
[33] L. Overbergh,et al. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. , 1999, Cytokine.
[34] L. Devi,et al. Neurotrophic Factors Regulate Cathepsin S in Macrophages and Microglia: A Role in the Degradation of Myelin Basic Protein and Amyloid β Peptide , 1999, Molecular medicine.
[35] J. Mesirov,et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[36] A. Newby,et al. Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. , 1999, Cardiovascular research.
[37] C. Overall,et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. , 2000, Science.
[38] T. Yue,et al. Expression of monocyte chemotactic protein-3 mRNA in rat vascular smooth muscle cells and in carotid artery after balloon angioplasty. , 2000, Biochimica et biophysica acta.
[39] M. Cybulsky,et al. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. , 2000, The Journal of clinical investigation.
[40] D. Rader,et al. Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice , 2000, The Journal of Immunology.
[41] A. Brinkmann,et al. Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: assessment of an analysis method , 2000, British Journal of Cancer.
[42] Y. Yuzawa,et al. Neointima formation in a restenosis model is suppressed in midkine-deficient mice. , 2000, The Journal of clinical investigation.
[43] A. Togias,et al. Nerve growth factor expression and release in allergic inflammatory disease of the upper airways. , 2000, American journal of respiratory and critical care medicine.
[44] G. Hansson,et al. Induction of CD36 by all-trans retinoic acid: retinoic acid receptor signaling in the pathogenesis of atherosclerosis. , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.